Screening of the ryanodine 1 gene for malignant hyperthermia causative mutations by high resolution melt curve analysis

Anesthesia and Analgesia

Volumn 113, Issue 5, 2011, Pages 1120-1128

  Broman, Marcus ^a   Heinecke, Kai ^b   Islander, Gunilla ^a   Schuster, Frank ^c   Glahn, Klaus ^d   Bodelsson, Mikael ^a   Treves, Susan ^e   Müller, Clemens ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d Mental Health Center Glostrup   (Denmark)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; RYANODINE RECEPTOR 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DNA EXTRACTION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; IN VITRO CONTRACTURE TEST; MALE; MALIGNANT HYPERTHERMIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 80055085351     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318228293e     Document Type: Article

References (24)

1. Hopkins PM. Malignant hyperthermia: advances in clinical management and diagnosis. Br J Anaesth 2000;85:118-28
2. Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006;27:977-89
3. Quinlivan RM, Mü ller C, Davis M, Laing NG, Evans GA, Dove J, Roberts AP, Sewry CA. Central core disease: clinical, pathological, and genetic features. Arch Dis Child 2003;88:1051-5
4. Ording H, Brancadoro V, Cozzolino S, Ellis FR, Glauber V, Gonano EF, Halsall PJ, Hartung E, Heffron JJ, Heytens L, Kozak-Ribbens G, Kress H, Krivosic-Horber R, Lehmann-Horn F, Mortier W, Nivoche Y, Ranklev-Twetman E, Sigurdsson S, Snoeck M, Stieglitz M, Tegazzin V, Urwyler A, Wappler F. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH group: results of testing patients surviving fulminant MH and unrelated lowrisk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 1997;41955-66
5. European Malignant Hyperthermia Group. Available at: www.emhg.org
6. Malignant Hyperthermia Association of the United States. Available at: www.mhaus.org
7. Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989;69:511-5
8. Broman M, Gehrig A, Islander G, Bodelsson M, Ranklev- Twetman E, Rü ffert H, Mü ller CR. Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases. Br J Anaesth 2009;102: 642-9
9. Galli L, Orrico A, Lorenzini S, Censini S, Falciani M, Covacci A, Tegazzin V, Sorrentino V. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia. Hum Mutat 2006 27 830-9.
10. Sambuughin N, Holley H, Muldoon S, Brandom B, de Bantel A, Tobin J, Nelson T, Goldfarb L. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population. Anesthesiology 2005;102:515-21
11. Weiss R, O'Connell K, Flucher B, Allen P, Grabner M, Dirksen R. Functional analysis of the R1068H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. Am J Physiol Cell Physiol 2004 287 1094-102.
12. Pirone A, Schredelseker J, Tuluc P, Gravino E, Fortunato G, Flucher BE, Carsana A, Salvatore F, Grabner M. Identification and functional characterization of malignant hyperthermia mutation T1354 S in the outer pore of the Cavalpha1S-subunit. Am J Physiol Cell Physiol 2010;299:1345-54
13. Weiss R, O'Connell K, Flucher B, Allen P, Grabner M, Dirksen R. Functional analysis of the R1068H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. Am J Physiol Cell Physiol 2004;287:1094-102
14. Urwyler A, Deufel T, McCarthy T, West S. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 2001;86:283-7
15. Taylor C. Mutation scanning using high-resolution melting. Biochem Soc Trans 2009;37:433-7
16. Larach MG, Localio AR, Allen GC, Denborough M, Ellis R, Gronert G, Kaplan R, Muldoon S, Nelson T, Ording H, Rosenberg H, Waud B, Wedel D. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994;80:771-9
17. Yu Q. M13 sequencing. Methods Mol Biol 2001;167:33-8
18. Erali M, Voelkerding KV, Wittwer CT. High resolution melting applications for clinical laboratory medicine. Exp Mol Pathol 2008;85:50-8
19. Vossen RH, Aten E, Roos A, den Dunnen JT. High-resolution melting analysis (HRMA): more than just sequence variant screening. Hum Mutat 2009;30:860-6
20. NCBI: dbSNP Short Genetic Variations. Available at: www.ncbi.nlm.nih.gov/ projects/SNP/
21. Grievink H, Stowell KM. Identification of ryanodine 1 singlenucleotide polymorphisms by high-resolution melting using the LightCycler 480 System. Anal Biochem 2008;2:396-404
22. Almomani R, van der Stoep N, Bakker E, den Dunnen JT, Breuning MH, Ginjaar B. Rapid and cost effective detection of small mutations in the DMD gene by high resolution melting curve analysis. Neuromuscul Disord 2009;19:383-90
23. Wittwer CT. High-resolution DNA melting analysis: advancements and limitations. Hum Mutat 2009;30:857-9
24. Tindall E, Petersen DC, Woodbridge P, Schipany K, Hayes V. Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments. Hum Mutat 2009;30:876-83